Latest "Sinclair Pharma Plc" News Stories

11:31 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Sinclair Pharma Plc" found in our extensive news archives from over 250 global news sources.

More Information about Sinclair Pharma Plc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sinclair Pharma Plc for you to read. Along with our medical data and news we also list Sinclair Pharma Plc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sinclair Pharma Plc Companies for you to search.

Showing "Sinclair Pharma" News Articles 1–25 of 6,600+

Saturday 21st July 2018

Indian Pharma Expo 2018 to be held from August 7 to 9

CIMS Medica will be presenting the 7th edition of Indian Pharma Expo (IPE) at Hall No. 12─A, Pragati Maidan, New Delhi from August 7 to 9, 2018

Shanghai Fosun Pharma Considering $500 Million IPO of Gland Pharma

Shanghai Fosun Pharma is considering an IPO of one of its recent acquisitions, the Indian drugmaker Gland Pharma, according to a Bloomberg report. If it decides to move ahead on the transaction, Fosun would seek to raise $500 million in an initial offering on an Indian exchange. In 2017, Fosun paid $1.1 billion for 74% ownership of Gland, a company known for its generic injectable products. More d...

#jobs #lifescience Bench Scientist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bench Scientist .CA-South San Francisco, South San Francisco, California Skills : • Minimum bachelor’s degree (+2 yrs)/ MS in cell biology, molecular biology, biochemistry, or related field • … Continue reading → Cet article #jobs #lifescience Bench Scientist...

#jobs #lifescience Principal Scientist, Drug Discovery Project Leader – Immunology – San Diego, CA

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Principal Scientist, Drug Discovery Project Leader – Immunology – San Diego, CA .CA-San Diego, By clicking the “Apply” button, I understand that my employment application process with Takeda … Continue reading → Cet article #jobs #lifescience Princi...

#jobs #lifescience Hemophilia Regional Business Director, Rare Disease – Pfizer Innovative Health – West Region

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Hemophilia Regional Business Director, Rare Disease – Pfizer Innovative Health – West Region .AZ-Young, All over the world, Pfizer colleagues are working together to positively impact health for … Continue reading → Cet article #jobs #lifescience Hemoph...

#jobs #lifescience Process Operator (608435)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Process Operator (608435) .MA-Braintree, Job Summary Performs drug product formulation, filling, crimping, sterilization, Visual inspection, labeling and Packaging. May be required to perform all or a combination of … Continue reading → Cet article #jobs #lifescien...

#jobs #lifescience HR Recruiting Coordinator

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: HR Recruiting Coordinator .MA-Boston, Are you interested in joining a growth-oriented company and would like to do so while working in a hot industry? A biotech company in … Continue reading → Cet article #jobs #lifescience HR Recruiting Coordinator est apparu en p...

Friday 20th July 2018

Week Ahead In Pharmaceuticals - 14 Stocks To Watch (LCI, INSY, TBPH...)

As another week comes to a close, let's take a look back at some of the stories that made headlines in the pharma space, and look ahead to what's in store in the coming week.

Israel Ampoules Packaging Market Segmented By Material Glass, Plastic, Applications Pharmaceuticals, Personal Care, Industrial Growth, Trends, And Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $3250

The Israel ampoules packaging market is expected to register a CAGR of about 6.72% during 20182023 the forecast period. The pharmaceutical sector of the country has evolved significantly over the last few decade, emerging as one of the biggest exporters of pharmaceutical products across the globe. Currently, the country is the fourthbiggest exporter of pharmaceutical products to the United States....

Neurodegenerative disorder start-up Neuraly closes $36mm Series A round

Neuraly Inc. (therapeutics that aim to reverse, stop, or slow neurodegeneration) brought in $36mm through a Series A round le...

Agios Pharma’s Drug for Rare Blood Cancer Wins Speedy FDA Nod

An Agios Pharmaceuticals drug developed to treat a rare form of leukemia has received FDA approval ahead of schedule. This marks the second time in the past year that the company has won the regulatory nod for a treatment for the disease, but this is the first approved drug that’s wholly owned by the Cambridge, […]

GlaxoSmithKline: health check

It makes no sense to rush a sale of consumer unit before pharma business strengthens

Tibsovo Approval Makes Agios’ Second AML Approval In A Year; Priced At $26k For 30 Days

Tibsovo is the second targeted therapy approved for a mutation-specific subset of relapsed/refractory AML patients. Agios discovered and jointly markets...    

Deal Watch: Gilead Continues To Add To IO Armamentarium In Collaboration With Gadeta

Deal through Kite Pharma subsidiary focuses on developing gamma delta T-cell receptor therapies. Sanofi inks SHP2 cancer collaboration with Revolution...  

MorphoSys, Galapagos ink global license pact with Novartis Pharma to develop & commercialise MOR106

MorphoSys AG and Galapagos NV have entered into a worldwide, exclusive agreement with Novartis Pharma AG covering the development and commercialization of their joint programme MOR106. MOR106 is an

Big Dope: why we shouldn’t rush to legalise medical cannabis

A powerful cannabis industry could emerge in the footsteps of Big Booze, Big Tobacco and Big Pharma, and we risk becoming beholden to it, says pharmacist Terry Maguire.

Merck Lowers Cost Of Zepatier, Says Its Committed To Avoiding Price Hikes

NewsAmid growing pressure by the Trump administration to reduce drug prices for U.S. patients, Merck has announced that the company will not increase the average net price across their product portfolio by more than inflation annually.

Pharma Q2 Results Preview: Lilly, Biogen, GSK And Gilead

Key strategy updates are coming: GSK will unveil its new R&D approach, Biogen will update investors on its Alzheimer's plans...   

Pharmalittle: Trump officials urge drug makers to lower prices; Drug dealers are sued for creating opioid crisis

Pharmalittle: Your daily rundown of all things pharma, by @edsilverman

Pharma Companies Try To Shift Blame To Drug Dealers, Websites As Real Culprits Of Opioid Epidemic

Endo International Plc and Mallinckrodt Plc are arguing that if they're added onto lawsuits for their role in the opioid crisis, they “are entitled to contribution from the illegal supply chain defendants." News on the crisis comes out of Pennsylvania and New Hampshire, as well.

PureTech signs potential $1bn exosome deal with Roche

US biotech PureTech Health has signed a potential billion-dollar deal with Roche based around its exosome technology that allows for oral administration of complex payloads – in this case antisense oligonucleotides developed by the Swiss pharma. P...

PureTech’s Milk Exosome-Based Technology Draws R&D Pact With Roche

PureTech's milk-derived exosome platform will be used by Roche to generate numerous novel antisense oligonucleotides, potentially earning PureTech more than...   

Roche und Merck & Co geben nach: Trump gewinnt

Immer mehr Pharma-Konzerne folgen Pfizer und verzichten vorerst auf die Erhöhung von Medikamentenpreisen in den USA. Nachdem bereits Novartis angekündigt hat, auf Preisanhebungen zu verzichten, zie...

Gilead develops solid tumour cell therapy with Gadeta

Gilead is making a mark with its Yescarta cell therapy in blood cancer, but like its rivals the California pharma is trying to find ways to get this approach to work in solid tumours. With this in mind Gilead’s subsidiary Kite has signed a deal wi...

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Large portfolios gives companies room for manoeuvre

Quick Search


News Quicklinks